Elite PharmaceuticalsELTP
13F holders, Q3 2025 (September 30)2holders +1
1new positions
0sold out
$0.64avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Elite Pharmaceuticals Inc. (ELTP) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Ancora Advisors LLC ($3K) and Kelleher Financial Advisors ($320).
- Company
- Elite Pharmaceuticals Inc.
- CUSIP
- 28659T200
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $320 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 500 shares bought, net +500 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Ancora Advisors LLC | 0.00% | No change | 5,182 | $3K |
| Kelleher Financial Advisors | 0.00% | New | 500 | $320 |
"% of holder's portfolio" is ELTP's weight in each manager's 13F, not the share of Elite Pharmaceuticals Inc. the manager owns.